Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meagher

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Urologic Oncology|May 24, 2025
Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablationGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Urologic Oncology|September 28, 2021
Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patientsJuan F Javier-DesLoges, Margaret F Meagher, Arman Walia, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
Urologic Oncology|September 3, 2025
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary systemMargaret F Meagher, Giacomo Musso, Viraj Master, et al.
Science (New York, N.Y.)|April 28, 2001
Observations of ozone formation in power plant plumes and implications for ozone control strategiesT B Ryerson, M Trainer, J S Holloway, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Journal of Clinical Medicine|June 13, 2025
Positive Surgical Margins in Clear Cell Renal Cell Carcinoma: Prognostic Impact and Implications for Risk Stratification and Adjuvant TherapyGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Urology Open Science|February 12, 2026
Histology-specific Prognostic Impact of Microscopic Positive Surgical Margins in Renal Cell Carcinoma: Implications for Postoperative SurveillanceGiacomo Musso, Margaret F Meagher, Mai Dabbas, et al.
Urology|June 27, 2025
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive ModelingGiacomo Musso, Natalie Birouty, Andrea Salonia, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Urologic Oncology|May 24, 2025
Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablationGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Urologic Oncology|September 28, 2021
Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patientsJuan F Javier-DesLoges, Margaret F Meagher, Arman Walia, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
Urologic Oncology|September 3, 2025
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary systemMargaret F Meagher, Giacomo Musso, Viraj Master, et al.
Science (New York, N.Y.)|April 28, 2001
Observations of ozone formation in power plant plumes and implications for ozone control strategiesT B Ryerson, M Trainer, J S Holloway, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Journal of Clinical Medicine|June 13, 2025
Positive Surgical Margins in Clear Cell Renal Cell Carcinoma: Prognostic Impact and Implications for Risk Stratification and Adjuvant TherapyGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Urology Open Science|February 12, 2026
Histology-specific Prognostic Impact of Microscopic Positive Surgical Margins in Renal Cell Carcinoma: Implications for Postoperative SurveillanceGiacomo Musso, Margaret F Meagher, Mai Dabbas, et al.
Urology|June 27, 2025
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive ModelingGiacomo Musso, Natalie Birouty, Andrea Salonia, et al.
Pageof 9